SWAV has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SWAV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Shockwave Medical's enterprise value is $12,068.3 Mil. Shockwave Medical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $191.5 Mil. Therefore, Shockwave Medical's EV-to-EBITDA for today is 63.01.
The historical rank and industry rank for Shockwave Medical's EV-to-EBITDA or its related term are showing as below:
During the past 7 years, the highest EV-to-EBITDA of Shockwave Medical was 233.42. The lowest was -1601.08. And the median was -19.32.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-17), Shockwave Medical's stock price is $327.50. Shockwave Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $3.870. Therefore, Shockwave Medical's PE Ratio for today is 84.63.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
The historical data trend for Shockwave Medical's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Shockwave Medical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Shockwave Medical's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Shockwave Medical's EV-to-EBITDA falls into.
Shockwave Medical's EV-to-EBITDA for today is calculated as:
EV-to-EBITDA | = | Enterprise Value (Today) | / | EBITDA (TTM) |
= | 12068.336 | / | 191.544 | |
= | 63.01 |
Shockwave Medical's current Enterprise Value is $12,068.3 Mil.
Shockwave Medical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $191.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shockwave Medical (NAS:SWAV) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Shockwave Medical's PE Ratio for today is calculated as:
PE Ratio | = | Share Price (Today) | / | Earnings per Share (Diluted) (TTM) |
= | 327.50 | / | 3.870 | |
= | 84.63 |
Shockwave Medical's share price for today is $327.50.
Shockwave Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.870.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Please read Which price ratio outperforms the enterprise multiple?
Thank you for viewing the detailed overview of Shockwave Medical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Douglas Evan Godshall | director, officer: President & CEO | SUITE 4 LEVEL 46 2 PARK STREET, SIDNEY C3 2000 |
Frank T Watkins | director | 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054 |
Isaac Zacharias | officer: Chief Commercial Officer | 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054 |
Dan Puckett | officer: CFO & Secretary | 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054 |
Trinh Phung | officer: VP, Finance | C/O SHOCKWAVE MEDICAL, INC., 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054 |
Laura Francis | director | C/O SI-BONE, INC., 471 EL CAMINO REAL, SUITE 101, SANTA CLARA CA 95050 |
Sara Toyloy | director | C/O SHOCKWAVE MEDICAL, INC., 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054 |
Kevin J. Ballinger | director | C/O BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752-1234 |
Maria Sainz | director | C/O ORTHOFIX INTERNATIONAL N. V., 3451 PLANO PARKWAY, LEWISVILLE TX 75056 |
Antoine Papiernik | director, 10 percent owner | 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054 |
Sofinnova Capital Vii Fcpr | 10 percent owner | C/O SOFINNOVA PARTNERS, 18 RUE DU 4 SEPTEMBRE, 75002 PARIS I0 00000 |
Cahill Colin | director | 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054 |
Frederic H Moll | director | C/O INTUITIVE SURGICAL INC, 950 KIFER ROAD, SUNNYVALE CA 94086 |
James E Flynn | 10 percent owner, other: Possible Member of 10% Group | 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017 |
Larkin C Raymond Jr | director | C/O MALLINCKRODT INC, 7733 FORSYTH BLVD, ST LOUIS MO 63105 |
From GuruFocus
By Marketwired • 09-12-2023
By GuruFocus Research • 12-19-2023
By Stock market mentor Stock market mentor • 01-31-2023
By Marketwired • 08-10-2023
By sperokesalga sperokesalga • 04-24-2023
By Marketwired • 08-11-2023
By Marketwired • 08-07-2023
By GuruFocus Research • 10-18-2023
By Marketwired • 10-20-2023
By Marketwired • 11-03-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.